Information sessions on the proposed regulation of homoeopathic and anthroposophic medicines, and essences, in the Australia New Zealand Therapeutic Products Authority (ANZTPA)
Medsafe and TGA would like to invite all interested stakeholders to an information session on the proposed approach to the regulation of homoeopathic and anthroposophic medicines, and essences, in the Australia New Zealand Therapeutic Products Authority (ANZTPA).
The aim of these information sessions is to:
- Clarify the proposed approach to the regulation of homoeopathic and anthroposophic medicines, and essences, which was developed on the basis of stakeholder comment.
- Outline strategies that are being considered to address such matters as practitioner availability and validity of product.
- Work with stakeholders to identify any outstanding issues and unintended consequences of the proposed system.
Two information sessions are planned, one in New Zealand and one in Australia.
The New Zealand Information Session will be held in Auckland:
| Venue: | Victoria Room Crowne Plaza Auckland 128 Albert St, Auckland |
|---|---|
| Date: | Tuesday 11 July 2006 |
| Time: | 1pm - 5pm |
The Australian Information Session will be held in Sydney:
| Venue: | Botany Room Stamford Plaza Sydney Airport cnr Robey & O'Riordan Streets Mascot |
|---|---|
| Date: | Thursday 13 July 2006 |
| Time: | 9am - 1pm |
All stakeholders who provided submissions on the Consultation Paper: Regulation of Homoeopathic and Related Medicines in a Joint Australia New Zealand Therapeutic Products Agency (released for comment in January 2006), and those who indicated an interest in attending these information sessions at the recent meetings held in June in Australia and New Zealand on the proposed joint regulatory scheme, have been sent individual invitations to the information sessions.
However, we also welcome the attendance and input of any other stakeholders who have an identified interest in the regulation of homoeopathic, anthroposophic or essence products. These sessions are intended to provide a comprehensive picture of the proposed regulatory system, and to help inform any submissions on the draft Medicines Rule.
We apologise for the short time frame and the limited dates available for these information sessions. However, as the ANZTPA stakeholder information meetings have only recently been completed, there were limited dates available that allowed sufficient time for stakeholder consideration of this matter before the deadline of 15 August 2006 (for comments on the consultation documents).
If you have any queries or concerns, please call Michelle McLaughlin on (+61) 02 6232 8476
URL: http://www.anztpa.org/cm/is-hae.htm